A detailed history of Fmr LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 5,823,356 shares of SAGE stock, worth $43.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,823,356
Previous 5,868,283 0.77%
Holding current value
$43.8 Million
Previous $110 Million 42.49%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$10.58 - $17.9 $475,327 - $804,193
-44,927 Reduced 0.77%
5,823,356 $63.2 Million
Q1 2024

May 13, 2024

BUY
$18.62 - $26.95 $7.18 Million - $10.4 Million
385,806 Added 7.04%
5,868,283 $110 Million
Q4 2023

Feb 13, 2024

SELL
$17.1 - $22.26 $37.9 Million - $49.3 Million
-2,213,578 Reduced 28.76%
5,482,477 $119 Million
Q3 2023

Nov 13, 2023

SELL
$16.75 - $48.98 $18.3 Million - $53.6 Million
-1,093,682 Reduced 12.44%
7,696,055 $158 Million
Q2 2023

Aug 11, 2023

BUY
$40.65 - $59.54 $69.4 Million - $102 Million
1,706,204 Added 24.09%
8,789,737 $413 Million
Q1 2023

May 11, 2023

BUY
$37.27 - $46.57 $19.8 Million - $24.8 Million
532,042 Added 8.12%
7,083,533 $297 Million
Q4 2022

Feb 13, 2023

BUY
$32.2 - $43.61 $7.53 Million - $10.2 Million
233,957 Added 3.7%
6,551,491 $250 Million
Q3 2022

Nov 10, 2022

BUY
$32.28 - $43.27 $11 Million - $14.7 Million
340,441 Added 5.7%
6,317,534 $247 Million
Q2 2022

Aug 12, 2022

BUY
$27.52 - $37.99 $9.51 Million - $13.1 Million
345,568 Added 6.14%
5,977,093 $193 Million
Q1 2022

May 13, 2022

BUY
$30.71 - $45.71 $4.33 Million - $6.44 Million
140,951 Added 2.57%
5,631,525 $186 Million
Q4 2021

Feb 14, 2022

SELL
$37.06 - $47.11 $5.43 Million - $6.9 Million
-146,510 Reduced 2.6%
5,490,574 $234 Million
Q3 2021

Nov 15, 2021

SELL
$40.26 - $57.37 $49.3 Million - $70.3 Million
-1,224,575 Reduced 17.85%
5,637,084 $250 Million
Q2 2021

Aug 13, 2021

BUY
$54.88 - $79.29 $377 Million - $544 Million
6,861,659 New
6,861,659 $390 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $447M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.